Add-on Acquisition • Life Science

Phagelux Acquires OmniLytics

On July 20, 2015, Phagelux acquired life science company OmniLytics

Acquisition Context

This is Phagelux’s 1st transaction in the Life Science sector.
This is Phagelux’s 1st transaction in the United States.
This is Phagelux’s 1st transaction in Utah.

Explore All 3116 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	July 20, 2015
Target	OmniLytics
Sector	Life Science
Buyer(s)	Phagelux
Deal Type	Add-on Acquisition

Target Company

OmniLytics

Sandy, Utah, United States

OmniLytics, Inc. is engaged in research and development of bacteriophage solutions for pathogen control in the fields of agriculture, food and water safety, and sanitation.

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Phagelux

Shanghai, China

Category	Company
Sector	Life Science

DESCRIPTION

Phagelux, Inc. is a developer of anti-bacterial solutions across multiple fields utilizing various phage and phage-based technologies and solutions.

Deal Context for Buyer	#
Overall	1 of 2
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Utah	1 of 1
Country: United States	1 of 1
Year: 2015	1 of 2

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2015-10-14	Scithera Microbial Technologies - Intellectual Property for Multiple Lysins China Scithera Microbial Technologies - Intellectual Property for Multiple Lysins is a provider of IT solutions to life science industry.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2015-10-14

Scithera Microbial Technologies - Intellectual Property for Multiple Lysins

China

Scithera Microbial Technologies - Intellectual Property for Multiple Lysins is a provider of IT solutions to life science industry.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Utah M&A - United States M&A - 2015 M&A